NEW ORLEANS--(BUSINESS WIRE)--ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 28, 2018 to file lead plaintiff applications in a securities class action lawsuit against Solid Biosciences Inc. (NasdaqGS: SLDB). Investor losses must relate to purchases of the Company’s shares between January 25, 2018, and March 14, 2018 or in its January 25, 2018 initial public offering. This action is pending in the United States District Court for the District of Massachusetts.
Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
On March 14, 2018, the Company disclosed a clinical hold placed on the trial of its lead drug candidate, SGT-001, by the U.S. Food and Drug Administration relating to the occurrence of adverse events. On this news, the price of Solid Biosciences’ shares plummeted over 60% to $9.32/share on March 15, 2018.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler’s team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.